Shorts

Michael S. Cookson, MD, on darolutamide’s safety profile

Jonathan D. Harper, MD, on increasing fluid intake to prevent recurrent stones

Nima Almassi, MD, on shared decision-making around bladder-preserving treatment options

Kathryn H. Gessner, MD, PhD, on the most exciting current developments in bladder cancer

Joshua J. Meeks, MD, PhD, on the need for recombinant BCG

Nicole L. Miller, MD, FACS, on what she tells patients after BPH treatment failure

Michael S. Cookson, MD, on what ARASEC adds to the treatment intensification discussion

Catherine A. Matthews, MD, FACS, on the U-POP & LUTD 2026 Global Consensus Conference

Hung-Jui (Ray) Tan, MD, MSHPM, on how urology can close the workforce gap in underserved areas

Boris Chertin, MD, and Raj S. Pruthi, MD, MHA, FACS, on the unique nature of NDV-01

James Nagarajah, MD, on the headline finding of BULLSEYE in HSPC

Savitha Krishnan, MD, on signs of prolapse urologists should watch for

Zach Feuer, MD, on the impact of wait times for prostate biopsy referral

María Natalia Gandur Quiroga, MD, MSc, discusses the evolution of immunotherapy in bladder cancer

Matthew Nielsen, MD, MS, FACS, shares what he’s looking forward to at AUA 2026

Amy E. Krambeck, MD, discusses the most common morcellation error in practice

Jihad Kaouk, MD, on innovation in patient care at Cleveland Clinic

María Natalia Gandur Quiroga, MD, MSc, on the most important recent advance in bladder cancer

Ramy Abou Ghayda, MD, MPH, on the UH Cutler Center for Men

Pedro-José López, MD, on discussing bladder exstrophy with parents

Jihad Kaouk, MD, on getting started with single-port surgery

Christopher Weight, MD, MS, on determining candidates for bladder preservation

Petar Bajic, MD, on when physicians should refer patients with Peyronie disease

J. Welles Henderson, MD, FACOG, on managing mixed urinary incontinence

David Wise, MD, on the efficacy of pasritamig plus docetaxel in mCRPC

Amy E. Krambeck, MD, on 3- vs 2-lobe enucleation for BPH

Mohit Khera, MD, MBA, MPH, on why FDA TRT announcement is a “big win”

The UroOnc Minute: Dr. Alfonso Gómez de Liaño Lista on implications of KEYNOTE-B15

Jesse N. Mills, MD, on why urologists need to be at the forefront of treating low libido

Landon Trost, MD, on the significance of the FDA announcement on idiopathic hypogonadism